The phosphatidylinositol-3 Kinase/protein kinase B (PI3K/Akt) and mitogen-activated protein kinase (MAPK/ERK) signaling pathways, among others, are frequently activated in a wide variety of human cancers, including leukemia, and other hematopoietic disorders. This evidence concerns the gene AKT1 and leukemia.